NEWS
Xingqi 2019 Milestones
Release time:2020-12-05 author:SINQI

Xinqi Ophthalmic Medications was named to the Advantageous Intellectual Property Enterprise by the China National Intellectual Property Administration in 2019.

WWW.DXY.CN presented “Xinqi 100”, the WeChat account of Sinqi Ophthalmic Medications, the “Med Digital Innovation Award” in 2019.

The General CPC Branch of Xinqi Ophthalmic Medications was upgraded to the CPC Committee upon the approval of the Organization Department of the Hunnan District Party Committee, Shenyang on March 14, 2019, which unfolded a new chapter of the party building work of the CPC Committee of Xinqi Ophthalmic Medications

Xinqi Ophthalmic Medications was included in the 2018 Listed Companies Practicing Active IR on March 20, 2019

Xinqi Ophthalmic Medications attended the COOC2019 in Shanghai on March 21, 2019

Zhang Lei, member of the Standing Committee of the Liaoning Provincial Party Committee and secretary of the Shenyang Municipal Party Committee, visited Xinqi Ophthalmic Medications for inspection and guidance on April 9, 2019

The three-in-one production line for the second eye drop production line, eye ointment/eye gel was recertified by GMP on April 24, 2019

Xinqi Ophthalmic Medications was named to the Top 100 Employers, Top 100 Technological Innovations and Top 100 Scales in the Private Sector of Shenyang in the first event for the selection and commendation of top 100 private enterprises in Shenyang held by the Shenyang Federation of Industry and Commerce in May 2019.

Xinqi Ophthalmic Medications was recertified by ISO9001:2015 in June 2019.

Xinqi Ophthalmic Medications aided the 2019 national eyesight protection activity – Keep Children’s Eyes Healthy and Keep their Future Bright – on June 6, 2019.

Xinqi Ophthalmic Medications was named to the Advanced Party Organization of Non-public Economic Organizations and Social Organizations in Hunnan District by the Organization Department of the Hunnan District Party Committee, Shenyang and was also granted a plaque in July 2019.

The multi-dose eye drop production line of Xinqi Ophthalmic Medications was recertified by GMP on July 3, 2019.

A delegate headed by Wan Donghua, chief of the Department of Society, Science and Culture of the National Bureau of Statistics, visited Xinqi Ophthalmic Medications on an inspection tour on August 6, 2019.

Xinqi Ophthalmic Medications was recognized as the Children and Adolescent Myopia Prevention and Control Engineering Research Center of Liaoning Province by the Provincial Engineering Research Center on November 1, 2019.

Xinqi Ophthalmic Medications obtained a new drug production license, according to which the company enriched the product portfolio with large-volume injections, inhalation preparations and ear preparations [ear drops (sterile)] on November 12, 2019.

Xinqi Ophthalmic Medications aided the Lifeline Express Brightness Action along the Belt and Road initiative in Uzbekistan on November 28, 2019. The company donated RMB 1 million to Lifeline Express in 3 years to subsidize the Lifeline Express Brightness Action along the Belt and Road charity program.

Xinqi Ophthalmic Medications was presented the Technological Innovation Award - 2019 Listed Company Golden Quality Award by the Shanghai Securities News in December 2019.

Xinqi Ophthalmic Medications worked with Shenyang Foundation for Disabled Persons to launch the donation ceremony for the Sinqi Ophthalmic Medications Aiding the Disabled Charity Program in Shenyang on December 2, 2019.

Xinqi Ophthalmic Medications held the inauguration ceremony for the CPC Party School (Administrative School) of the CPC Committee of Sinqi Ophthalmic Medications in Shaoshan, Hunan on December 21, 2019 and carried out the first Talent Reserve Plan training of the Marketing Center.